199 related articles for article (PubMed ID: 11669456)
41. Interactions of human organic anion transporters with diuretics.
Hasannejad H; Takeda M; Taki K; Shin HJ; Babu E; Jutabha P; Khamdang S; Aleboyeh M; Onozato ML; Tojo A; Enomoto A; Anzai N; Narikawa S; Huang XL; Niwa T; Endou H
J Pharmacol Exp Ther; 2004 Mar; 308(3):1021-9. PubMed ID: 14610216
[TBL] [Abstract][Full Text] [Related]
42. Characterization of uremic toxin transport by organic anion transporters in the kidney.
Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
[TBL] [Abstract][Full Text] [Related]
43. Peritubular transport of ochratoxin A in rabbit renal proximal tubules.
Groves CE; Morales M; Wright SH
J Pharmacol Exp Ther; 1998 Mar; 284(3):943-8. PubMed ID: 9495853
[TBL] [Abstract][Full Text] [Related]
44. Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Taniguchi R; Motohashi H; Saito H; Okuda M; Inui K
Drug Metab Pharmacokinet; 2004 Oct; 19(5):369-74. PubMed ID: 15548848
[TBL] [Abstract][Full Text] [Related]
45. Renal organic anion transporters OAT1 and OAT3 mediate the cellular accumulation of 5-sulfooxymethylfurfural, a reactive, nephrotoxic metabolite of the Maillard product 5-hydroxymethylfurfural.
Bakhiya N; Monien B; Frank H; Seidel A; Glatt H
Biochem Pharmacol; 2009 Aug; 78(4):414-9. PubMed ID: 19394312
[TBL] [Abstract][Full Text] [Related]
46. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Motohashi H; Uwai Y; Hiramoto K; Okuda M; Inui K
Eur J Pharmacol; 2004 Oct; 503(1-3):25-30. PubMed ID: 15496291
[TBL] [Abstract][Full Text] [Related]
47. A novel human organic anion transporter NPT4 mediates the transport of ochratoxin A.
Jutabha P; Anzai N; Hayashi K; Domae M; Uchida K; Endou H; Sakurai H
J Pharmacol Sci; 2011; 116(4):392-6. PubMed ID: 21778665
[TBL] [Abstract][Full Text] [Related]
48. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1.
Whitley AC; Sweet DH; Walle T
Drug Metab Dispos; 2005 Aug; 33(8):1097-100. PubMed ID: 15870380
[TBL] [Abstract][Full Text] [Related]
49. Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells.
Cai H; Agrawal AK; Putt DA; Hashim M; Reddy A; Brodfuehrer J; Surendran N; Lash LH
Toxicology; 2009 Apr; 258(1):56-63. PubMed ID: 19378467
[TBL] [Abstract][Full Text] [Related]
50. Transport of xanthurenic acid by rat/human organic anion transporters OAT1 and OAT3.
Uwai Y; Honjo E
Biosci Biotechnol Biochem; 2013; 77(7):1517-21. PubMed ID: 23832370
[TBL] [Abstract][Full Text] [Related]
51. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity.
Enomoto A; Takeda M; Tojo A; Sekine T; Cha SH; Khamdang S; Takayama F; Aoyama I; Nakamura S; Endou H; Niwa T
J Am Soc Nephrol; 2002 Jul; 13(7):1711-20. PubMed ID: 12089366
[TBL] [Abstract][Full Text] [Related]
52. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
[TBL] [Abstract][Full Text] [Related]
53. Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein.
Chu XY; Bleasby K; Yabut J; Cai X; Chan GH; Hafey MJ; Xu S; Bergman AJ; Braun MP; Dean DC; Evers R
J Pharmacol Exp Ther; 2007 May; 321(2):673-83. PubMed ID: 17314201
[TBL] [Abstract][Full Text] [Related]
54. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
55. Transport of ochratoxin A by renal multispecific organic anion transporter 1.
Tsuda M; Sekine T; Takeda M; Cha SH; Kanai Y; Kimura M; Endou H
J Pharmacol Exp Ther; 1999 Jun; 289(3):1301-5. PubMed ID: 10336520
[TBL] [Abstract][Full Text] [Related]
56. Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules.
Lungkaphin A; Chatsudthipong V; Evans KK; Groves CE; Wright SH; Dantzler WH
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F68-76. PubMed ID: 13129851
[TBL] [Abstract][Full Text] [Related]
57. Characterization of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, and meropenem as substrates of human renal transporters.
Shibayama T; Sugiyama D; Kamiyama E; Tokui T; Hirota T; Ikeda T
Drug Metab Pharmacokinet; 2007 Feb; 22(1):41-7. PubMed ID: 17329910
[TBL] [Abstract][Full Text] [Related]
58. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
59. Functional characterization and comparison of human and mouse organic anion transporter 1 as drugs and pesticides uptake carrier.
Floerl S; Kuehne A; Hagos Y
Eur J Pharm Sci; 2022 Aug; 175():106217. PubMed ID: 35644507
[TBL] [Abstract][Full Text] [Related]
60. Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors.
Cihlar T; Ray AS; Laflamme G; Vela JE; Tong L; Fuller MD; Roy A; Rhodes GR
Antivir Ther; 2007; 12(2):267-72. PubMed ID: 17503669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
